Nexiam (R) 2.5 mg and 5 mg sachets

被引：0
|
作者：
不详
机构：
来源：
SA PHARMACEUTICAL JOURNAL | 2015年 / 82卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：30 / 31
页数：2
相关论文
共 50 条
  • [41] Prophylactic treatment of migraine with flunarizine: 5 mg or 10 mg?
    Cano, A
    Palomeras, E
    Sanz, P
    Fossas, P
    REVISTA DE NEUROLOGIA, 2001, 33 (01) : 96 - 97
  • [42] Hydrogen Uptake and Release Characteristics of Mg-xTaF5-xVCl3 (x=1.25, 2.5, and 5)
    Song, Myoung Youp
    Kwak, Young Jun
    KOREAN JOURNAL OF METALS AND MATERIALS, 2018, 56 (08): : 611 - 619
  • [43] Valsartan 160 mg/Amlodipine 5 mg Combination Therapy versus Amlodipine 10 mg in Hypertensive Patients with Inadequate Response to Amlodipine 5 mg Monotherapy
    Sung, Jidong
    Jeong, Jin-Ok
    Kwon, Sung Uk
    Won, Kyung Heon
    Kim, Byung Jin
    Cho, Byung Ryul
    Kim, Myeong-Kon
    Lee, Sahng
    Kim, Hak Jin
    Lim, Seong-Hoon
    Park, Seung Woo
    Park, Jeong Euy
    KOREAN CIRCULATION JOURNAL, 2016, 46 (02) : 222 - 228
  • [44] Hot Compression Deformation Behavior of the Mg-5Sn-2.5Pb Magnesium Alloy
    Xie, Pin
    Zhu, Yun-Peng
    Jin, Pei-Peng
    PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON MATERIAL SCIENCE AND APPLICATIONS (ICMSA 2015), 2015, 3 : 612 - 617
  • [45] Losartan Potassium 2.5 mg/mL Oral Suspension
    Allen, Loyd V.
    US PHARMACIST, 2012, 37 (09) : 46 - 47
  • [46] Sildenafil Citrate 2.5 mg/mL Oral Liquid
    Allen, Loyd V., Jr.
    US PHARMACIST, 2018, 43 (02) : 47 - 48
  • [47] CONTRACEPTIVE EFFICACY OF ONCE-WEEKLY ORAL-ADMINISTRATION OF 2.5 MG R-2323
    SAKIZ, E
    AZADIANBOULANGER, G
    OJASOO, T
    LARAQUE, F
    CONTRACEPTION, 1976, 14 (03) : 275 - 284
  • [48] Oral anticoagulant therapy (OAT) following heart valve replacement (HVR): Comparison of a daily fixed 2.5 mg with a 5 mg, INR adjusted, dose
    Ageno, W
    Turpie, AGG
    Steidl, L
    Codari, RL
    Ambrosini, F
    Cattaneo, R
    Nardo, B
    Barlocco, E
    Castelli, N
    Tarelli, G
    Benco, A
    THROMBOSIS AND HAEMOSTASIS, 1999, : 549 - 550
  • [49] 2.5mg和5mg地塞米松对罗哌卡因臂丛阻滞效果的影响
    胡光俊
    李莉
    宋晓阳
    黎笔熙
    甘国胜
    天津医药, 2020, 48 (10) : 997 - 1000
  • [50] Comparison of the pharmacokinetics of lansoprazole 15-and 30-mg sachets for suspension versus intact capsules
    Amer, F
    Karol, MD
    Pan, WJ
    Griffin, JS
    Lukasik, NL
    Locke, CS
    Chiu, YL
    CLINICAL THERAPEUTICS, 2004, 26 (12) : 2076 - 2083
12345